90 filings
8-K
BRNS
Barinthus Biotherapeutics Plc.
15 May 24
Submission of Matters to a Vote of Security Holders
4:07pm
8-K/A
BRNS
Barinthus Biotherapeutics Plc.
14 May 24
Barinthus Bio Reports First Quarter 2024 Financial Results and Update on Corporate Developments
4:02pm
10-Q
2024 Q1
BRNS
Barinthus Biotherapeutics Plc.
Quarterly report
13 May 24
8:13am
8-K
BRNS
Barinthus Biotherapeutics Plc.
13 May 24
Barinthus Bio Reports First Quarter 2024 Financial Results and Update on Corporate Developments
8:07am
8-K
BRNS
Barinthus Biotherapeutics Plc.
18 Apr 24
Barinthus Bio Announces Topline Data from Phase 1b/2 APOLLO Trial of VTP-200 in Persistent High-Risk Human Papillomavirus (HPV) Infections
4:15pm
ARS
2d541gdwzmz861pq
22 Mar 24
Annual report to shareholders
8:43am
DEFA14A
0b06zzt1jqe8uenj
22 Mar 24
Additional proxy soliciting materials
8:41am
S-8
hasg1rb9lrha
20 Mar 24
Registration of securities for employees
5:02pm
8-K
yimg 52tsz
20 Mar 24
Barinthus Bio Reports Full Year 2023 Financial Results and Update on Corporate Developments
8:24am
8-K
nvbob2vwro
5 Jan 24
Barinthus Bio Provides a Financial Update and Announces Anticipated 2024 Corporate Milestones
4:15pm
8-K
rnoja4su9 m9i5
22 Dec 23
New partnership aims to advance vaccine against MERS coronavirus
4:01pm
8-K
wtjsroehc9oeg9ki8v3l
9 Nov 23
Regulation FD Disclosure
4:32pm
8-K
wllrbue ja
9 Nov 23
Barinthus Bio Reports Third Quarter 2023 Financial Results and Recent Corporate Developments
4:10pm
8-K
komksn39npbkn4
6 Nov 23
Submission of Matters to a Vote of Security Holders
11:04am
PRE 14A
66kcg
25 Sep 23
Preliminary proxy
5:19pm